Chimeric antigen receptor T-cell therapy uses a patients’ T-cells to fight cancer. Although more than half of recipients go into remission, the treatment costs $375,000 to $475,000, NBC News reported.
Read the full post on Becker's Hospital Review - Healthcare News
